Related Experiment Video
Updated: Jun 13, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Disorders of hemostasis associated with chronic kidney disease
Diana I Jalal1, Michel Chonchol, Giovanni Targher
1Division of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO, USA.
Insights
Chronic kidney disease (CKD) patients face conflicting bleeding and clotting risks. This review explores hemostasis abnormalities in CKD and current treatment options for these complex hemostatic disorders.
Area of Science:
- Nephrology
- Hematology
Background:
- Chronic kidney disease (CKD) is a significant global health issue.
- Patients with CKD exhibit a prothrombotic tendency, especially in advanced stages.
- Advanced CKD can also present with a bleeding diathesis, a complex hemostatic disorder.
Purpose of the Study:
- To critically review studies on hemostatic pathway abnormalities in CKD patients.
- To examine the current therapeutic strategies for managing hemostatic disorders in CKD.
Main Methods:
- Literature review of studies on hemostasis in CKD.
- Appraisal of research on prothrombotic and bleeding tendencies in CKD patients.
Main Results:
- CKD is linked to both increased clotting and bleeding risks.
- The precise causes of these conflicting hemostatic issues in CKD remain unclear.
Conclusions:
- Understanding CKD-associated hemostatic abnormalities is crucial.
- Further research is needed to clarify the etiology and optimize treatments for these disorders.
Abstract:
Chronic kidney disease (CKD) is a growing global health problem. CKD is typically associated with a prothrombotic tendency in the early stages of the disease, whereas in its more advanced stage, that is, end-stage renal disease, patients suffer from a prothrombotic tendency and, in many cases, a bleeding diathesis. The exact etiology behind the coexistence of these conflicting hemostatic disorders is poorly understood. This review critically appraises studies examining the abnormalities in the hemostasis pathway in patients with CKD, as well as the therapeutic options that are currently available to treat these individuals.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury II: Pathophysiology
